期刊文献+

胰岛素样生长因子1及其受体在卵巢癌细胞增殖中的作用 被引量:8

Effects of insulin-1ike growth factor 1 and its receptor on proliferation of ovarian cancer cells
下载PDF
导出
摘要 目的探讨胰岛素样生长因子1(IGF1)及其受体(IGF1R)在卵巢癌HO8910PM细胞增殖中的作用。方法以不同浓度的IGF1作用于HO8910PM细胞24、48、72和96 h,通过CCK-8法检测细胞增殖活性;在脂质体介导下转染特异性IGF1R小干扰RNA(siRNA),通过实时PCR和Western blotting验证其在IGF1R mRNA和蛋白表达水平的抑制效果;于转染后48 h给予IGF1刺激,通过CCK-8法测定细胞增殖活性。结果IGF1作用48 h后可明显刺激细胞的增殖(P<0.05);转染IGF1R siRNA后48 h,IGF1R mRNA和蛋白表达均明显下调(P<0.05);转染IGF1R siRNA后48 h给予IGF1刺激,IGF1的促细胞增殖效应明显被抑制(P<0.05)。结论IGF1通过IGF1R途径促进HO8910PM细胞的增殖,IGF1R siRNA可以有效抑制该作用。 Objective To investigate the effects of insulin-like growth factor 1 (IGF1) and IGF1 receptor(IGF1R) on proliferation of HO8910PM cells of ovarian cancer. Methods The effects of IGF1 of different concentration on HO8910PM cells were observed by CCK-8 assay. Transfection of IGF1R siRNA by lipofectamine 2000 to silence IGF1R gene expression in HO8910PM, the silence effects were evaluated by real-time PCR and Western blotting. Forty-eight hours after transfection, IGF1 was added on HO8910PM cells to observe the effects on proliferation by CCK-8 assay. Results Incubation with IGF1 for 48 h significantly stimulated the proliferation response of HO8910PM cells (P 〈 0.05). IGF1R mRNA and protein expression levels were significantly decreased by transfecting IGF1R siRNA for 48 h ( P 〈 0.05). After transfection of IGF1R siRNA for 48 h and incubation with IGF1, the stimulation of proliferation response was significantly down-regulated (P 〈 0.05). Conclusion IGF1 stimulates the proliferation response of HO8910PM cells by IGF1R pathway. IGF1R siRNA may effectively down-regulate the effects.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2008年第3期270-272,共3页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(30471808) 上海市科委基金(04JC14045)~~
关键词 胰岛素样生长因子 受体 卵巢癌 小干扰RNA 增殖 insulin-like growth factor recepter ovarian cancer small interference RNA proliferation
  • 相关文献

参考文献1

二级参考文献45

  • 1[1]Weitz J,Koch M,Debus J,Hohler T,Galle PR,Buchler MW.Colorectal cancer.Lancet 2005; 365:153-165 被引量:1
  • 2[2]Rougier P,Mitry E.Epidemiology,treatment and chemoprevention in colorectal cancer.Ann Oncol 2003; 14Suppl 2:ii3-5 被引量:1
  • 3[3]Larsson O,Girnita A,Girnita L.Role of insulin-like growth factor 1 receptor signalling in cancer.Br J Cancer 2005; 92:2097-2101 被引量:1
  • 4[4]Hakam A,Yeatman TJ,Lu L,Mora L,Marcet G,Nicosia SV,Karl RC,Coppola D.Expression of insulin-like growth factor-1 receptor in human colorectal cancer.Hum Pathol 1999; 30:1128-1133 被引量:1
  • 5[5]Weber MM,Fottner C,Liu SB,Jung MC,Engelhardt D,Baretton GB.Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.Cancer 2002; 95:2086-2095 被引量:1
  • 6[6]Ullrich A,Schlessinger J.Signal transduction by receptors with tyrosine kinase activity.Cell 1990; 61:203-212 被引量:1
  • 7[7]van der Geer P,Hunter T,Lindberg RA.Receptor proteintyrosine kinases and their signal transduction pathways.Annu Rev Cell Biol 1994; 10:251-337 被引量:1
  • 8[8]Wang Y,Sun Y.Insulin-like growth factor receptor-1 as an anti-cancer target:blocking transformation and inducing apoptosis.Curr Cancer Drug Targets 2002; 2:191-207 被引量:1
  • 9[9]Baserga R.The contradictions of the insulin-like growth factor 1 receptor.Oncogene 2000; 19:5574-5581 被引量:1
  • 10[10]Schoen RE,Weissfeld JL,Kuller LH,Thaete FL,Evans RW,Hayes RB,Rosen CJ.Insulin-like growth factor-Ⅰ and insulin are associated with the presence and advancement of adenomatous polyps.Gastroenterology 2005; 129:464-475 被引量:1

共引文献9

同被引文献69

引证文献8

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部